Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds

(2010) Umesh M. Hanumegowda et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Testing Susceptibility of Multidrug-Resistant Mycobacterium tuberculosis to Second-Line Drugs by Use of Blood Agar

(2010) D. Satana et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays

(2010) Natalie Mesens et al.   TOXICOLOGY IN VITRO

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

(2009) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa

(2009) Kwonjune J. Seung et al.   PLoS One

Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis

(2008) R. Rustomjee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY